Durgical
EN
Open the app

Mechanisms of neuronal injury: excitotoxicity, calcium, free radicals, axon death and protein aggregation

  • Mechanism

Stroke, trauma, seizures and dementias kill neurons through a few shared routes. Knowing them explains the timing of damage and why rescue drugs failed.

Updated

What it is

Neurons die through a few overlapping routes: excess glutamate lets calcium in (excitotoxicity), calcium switches on destructive enzymes and overloads mitochondria, and free radicals form. The severity of the hit decides necrosis or apoptosis. A cut axon runs its own self-destruct programme, and in chronic disease misfolded proteins aggregate.

Step by step

  1. Blood flow or glucose fails: ATP falls and ion pumps and glutamate transporters stop.
  2. Glutamate builds up outside neurons within minutes and over-activates NMDA and AMPA receptors.
  3. Sodium, chloride and water enter: the neuron swells (cytotoxic oedema), which is still reversible.
  4. Calcium floods in and is released from stores; calpains, lipases, endonucleases and nNOS switch on.
  5. Mitochondria overload with calcium, lose their potential and leak cytochrome c and AIF; free radicals and peroxynitrite form.
  6. Massive failure gives necrosis in hours; milder failure gives caspase-driven or PARP-driven (parthanatos) death over hours to days.
  7. From about 6 to 12 hours red neurons appear; microglia and macrophages clear debris and astrocytes scar.

Five routes to neuronal death and where each dominates

RouteTriggerWhat it doesWhere it dominates
ExcitotoxicityExcess glutamate on NMDA and AMPA receptorsSodium swelling, then calcium overloadStroke, cardiac arrest, trauma, status epilepticus, severe hypoglycaemia
Calcium and mitochondrial failureCalcium entry plus ATP lossCalpains, lipases, endonucleases; mitochondrial pore opening and cytochrome c releaseEvery acute injury; chronic overload in neurodegeneration
Oxidative and nitrosative stressMitochondrial leak, nNOS, reperfusionPeroxynitrite damages lipids and DNA; PARP overactivation drains energyReperfusion after stroke, trauma; a contributor in neurodegeneration
Axon death (Wallerian degeneration)Axon cut, crushed or starved of transportNMNAT2 falls, SARM1 consumes NAD⁺, the axon fragments; glia clear itNerve and spinal cord injury, traumatic brain injury, chemotherapy-induced neuropathy
Protein aggregationMisfolded amyloid-beta, tau, alpha-synuclein, huntingtin, TDP-43Synapse loss, impaired transport and protein clearance, slow deathAlzheimer, Parkinson, Huntington disease, ALS

Clinical notes

  • In stroke the penumbra is threatened tissue whose neurons are dying more slowly; restoring flow early is the only proven way to save it.
  • Drugs that block NMDA receptors protected neurons in animals but failed in stroke trials: they were given hours late, at doses limited by side effects such as hallucinations.
  • After a brief cardiac arrest, selectively vulnerable neurons (hippocampal CA1, Purkinje cells) can die days later by delayed apoptosis, so injury can keep progressing after the circulation is restored.
  • In neurodegenerative disease, synapses and dendrites are lost long before neurons die, which is why symptoms begin before cell counts fall.

Common traps

  • Sodium entry is what kills the neuron in excitotoxicity: sodium causes the early swelling, which is often reversible; calcium overload drives the irreversible injury.
  • Neurons in a stroke die only by necrosis: the core dies by necrosis, but milder insults in the penumbra and in vulnerable neurons trigger apoptosis hours to days later.
  • Wallerian degeneration is a passive wasting of a cut axon: it is an active programme; the distal axon loses its survival factor NMNAT2 and SARM1 destroys its NAD⁺.
  • Blocking glutamate receptors should rescue the stroke brain: NMDA antagonists failed in trials, partly because they came too late and partly because deep blockade can push neurons into apoptosis.
  • Protein aggregates are proven to be what kills neurons: aggregates mark disease severity, but some may be by-products or even protective; synapse loss starts earlier.

Test yourself

Think of the answer, then tap the question to see it.

Why does glutamate accumulate outside neurons within minutes of a stroke?

Its removal depends on ATP-driven transporters in astrocytes and nerve endings; ischaemia stops ATP production, so glutamate is no longer cleared and depolarised terminals keep releasing it.

In excitotoxicity, which ion causes the early swelling and which causes irreversible death?

Sodium (with chloride and water) causes the early, often reversible swelling; calcium overload activates enzymes and damages mitochondria, causing irreversible injury.

How does NMDA receptor activation lead to DNA damage and energy failure?

Calcium activates neuronal nitric oxide synthase; NO combines with superoxide to form peroxynitrite, which breaks DNA; PARP overactivation then drains NAD⁺ and ATP and releases AIF.

Why can an axon cut from its cell body still look normal for several hours before it fragments?

It survives on its remaining NMNAT2, a short-lived factor shipped from the soma; when NMNAT2 falls below threshold, SARM1 consumes NAD⁺ and the axon breaks up.

What are two reasons why NMDA antagonists failed as stroke treatments?

They were given hours after onset, at doses limited by side effects such as hallucinations; and strong blockade may lower calcium below a survival level and favour apoptosis.

Add to my cards (5)

More Pathology questions →

Elsewhere in DurgiPedia

Connections

← All of general pathology

Educational content on the mechanisms of disease; not a diagnostic or treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Excitotoxicity: Still Hammering the Ischemic Brain in 2020 (Frontiers in Neuroscience, 2020); Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration (Translational Neurodegeneration, 2022); Axon death signalling in Wallerian degeneration among species and in disease (Open Biology, 2019); Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases (International Journal of Molecular Sciences, 2018).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.